MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium ProgramShimin Hu, Ken H. Young, Santiago Montes‐Moreno et al.|Blood|2013Cited by 677
mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3- mutated acute myeloid leukemia cellsWeina Chen, George Z. Rassidakis|Molecular Cancer|2010Cited by 105
Prognostic Factors of Hepatosplenic T-cell LymphomaMariko Yabe, Roberto N. Miranda, L. Jeffrey Medeiros et al.|The American Journal of Surgical Pathology|2016Cited by 82
Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomasAdam C. Seegmiller, Weina Chen|Modern Pathology|2010Cited by 61
miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKTWeina Chen, Tong Wu|PLoS ONE|2015Cited by 27